Your current web browser is outdated. For best viewing experience, please consider upgrading to the latest version.

Contact

Send a question or comment using the form below. This message may be routed through support staff.

Email Article

RSVP

Forum

Solving the Drug-Pricing Challenge

Tom Coburn, MD Nick Ohnell Fellow, Manhattan Institute; former U.S. Senator
Wed, Jun 14, 2017 Washington, D.C.

Thank you for your RSVP.

ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
ERROR
Main Error Mesage Here
More detailed message would go here to provide context for the user and how to proceed
search DONATE
Close Nav

Solving the Drug-Pricing Challenge

back to top
SEE ALL EVENTS
Forum

Solving the Drug-Pricing Challenge: Policy Reforms to Expand Drug Access, Accelerate Innovation, and Grow the Economy

Tom Coburn, MD Nick Ohnell Fellow, Manhattan Institute; former U.S. Senator
Washington, D.C. 09:00am—10:30am
Wednesday June 14
Wednesday June 14 2017
PAST EVENT Wednesday June 14 2017

Co-sponsored by U.S. Chamber of Commerce

America is the world leader in medical innovation, producing medicines that improve and extend the lives of millions of patients at home and abroad. The biotech industry is also one of the U.S.’s economic crown jewels, generating hundreds of thousands of high-paying jobs and billions of dollars in high-value exports.

Populist solutions to high drug prices, such as price controls and drug importation, will discourage investment in the costly, time-consuming research and development of vital new treatments and cures. Rather than focus on drug prices in a silo, policymakers should explore solutions that ensure that Americans have access to affordable prescription drugs without discouraging innovation.

Solutions include policies that protect U.S. intellectual property overseas, so that other countries contribute to global R&D burdens; tax policies that encourage U.S.-based investment and manufacturing; and regulatory reforms that spur competition, encouraging providers and insurers to seek out technologies that deliver better outcomes for patients. Please join MI and the U.S. Chamber of Commerce for a discussion on the drug-pricing challenge.

MEDIA CONTACT

212-599-7000
communications@manhattan-institute.org

TOPICS
Health PolicyDrug Development

Program

9:00 - 9:15 AM
Registration/Reception

9:15 - 9:45 AM
Keynote:
Tom Coburn, Nick Ohnell Fellow, MI

9:45 - 10:15 AM
Panel Discussion:
Ernst Berndt, Professor, MIT Sloan
Paul Howard, Director and Senior Fellow, MI
Benjamin Roin, Assistant Professor, MIT Sloan
Moderator: David Nather, Editor, Axios

10:15 - 10:30 AM
Audience Q&A
 

Saved!
Close